# BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations

Study · id `cardio:ct-nct03548272` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03548272](<https://clinicaltrials.gov/study/NCT03548272>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03548272

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 518 participants.

## Technical summary

Registry record NCT03548272. Randomized; single masking; primary purpose treatment. Start 2018-06-12 (actual); primary completion 2019-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 518 participants (planned count; ClinicalTrials.gov record NCT03548272, source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)
- Started: 2018-06-12 (actual) (ClinicalTrials.gov record NCT03548272, source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)
- Primary completion: 2019-06 (anticipated) (ClinicalTrials.gov record NCT03548272, source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)
- Completion: 2020-06 (anticipated) (ClinicalTrials.gov record NCT03548272, source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT03548272, source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03548272-2018-07-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations
- Acronym: POLBOS 3
- Condition: Coronary Artery Disease
- Intervention (Procedure): Percutaneous Coronary Intervention with stent implantation
- Lead sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland (`cardio:org-central-clinical-hospital-of-the-ministry-of-internal-03f889`)

## Provenance

Content hash: f41d15f97cddba1268ab2c43cfcc11b6b672e280b18b151a535fc3825fb8f5fd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
